Ibandronate: Side Effects, Overdose and Pregnancy Information
Ibandronate is a type of drug known as bisphosphonate. Bisphosphonate in Ibandronate prevents the bone loss
by slowing down calcium loss from bones. Ibandronate is used to treat osteoporosis in menopausal women. In these women Ibandronate has been shown to reduce the risk of breaking a bone in the spine, but it is not known if Ibandronate is effective at preventing hip fractures. Ibandronate can also be used to prevent bone damage when Breast Cancer has spread to the bones.
IBANDRONATE SIDE EFFECTS
Common Ibandronate side effects may include allergic reactions such as skin rash or itching or hives,
black stools,
change in vision,
chest pain,
heartburn, stomach pain,
jaw pain, redness of the skin,
trouble swallowing , and swelling of the face, lips, throat or tongue.
Rare side effects of Ibandronate may include
muscle or bone pain,
changes in taste,
diarrhea, constipation,
headache,
nausea, vomiting, and gas.
Ibandronate Warning and Caution
Ibandronate can cause irritation and ulceration of the esophagus.
Ibandronate tablet should be taken on the same date each month, in the morning after an overnight fast of at least six hours. Ibandronate should be swallowed whole with a glass of plain water (no mineral water) while you are sitting or standing in an upright position. Do not chew or suck the tablet. You should not lie down for one hour after taking your Ibandronate tablet. You should not eat or drink anything other than plain water for one hour after taking Ibandronate as food and some drinks (including mineral water) can interfere with the absorption of Ibandronate therefore make it less effective.
Avoid taking any other drug by mouth in the six hours before you take your Ibandronate tablet, at the same time as your Ibandronate tablet, or in the hour after you have taken the tablet.
Upon experiencing any signs of problems with swallowing, pain on swallowing, pain behind your chest bone, or heartburn, stop taking Ibandronate and inform your physician.
Bisphosphonates in Ibandronate has been linked with a rare condition called osteonecrosis of the jaw. The majority of cases of this condition have been in cancer patients treated with bisphosphonates by injection into a vein and many of these patients were also having treatment with chemotherapy or corticosteroids. However, the condition has also been seen in people taking bisphosphonates by mouth. The risk may be increased by poor dental hygiene, dental problems, tooth extractions and dental surgery.
Ibandronate should be used with caution in
decreased kidney function,
disorders of the thyroid glands, and
vitamin D deficiency.
Ibandronate should not to be used in
low levels of calcium in the blood (hypocalcaemia),
women who are unable to stand or sit upright for at least one hour,
Ibandronate and Pregnancy
Ibandronate has not been studied in pregnant women; therefore its safety has not been established. Ibandronate should not be used during pregnancy.
It is not known if Ibandronate passes into breast milk. Nursing mothers should switch to bottle-feed while using Ibandronate.
Ibandronate Overdose
Ibandronate overdose symptoms may include nausea, heartburn, stomach pain, diarrhea, muscle cramps, numbness or tingling, seizure, irritability, and unusual thoughts or behavior. In case of Ibandronate Overdose seek medical attention right away.
If you forget to take your monthly Ibandronate tablet, you should take it the morning after you remember, and then return to taking it once a month on your normal date. However, if you miss a dose of Ibandronate but realize that your next dose is due in the next seven days, forget the missed dose and take your next scheduled dose on the day you would normally take it. You should not take two Ibandronate tablets within the same week.
A-Z Drug List
